Achieve Life Sciences Inc (ACHV)

$3.16 -0.12 (-3.66%)
Market Cap 167.62M
Revenue (ttm) 0.00
Net Income (ttm) -39.83M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.03
Volume 1,558,900
Avg Vol 1,257,970
Day's Range N/A - N/A
Shares Out 51.11M
Stochastic %K 77%
Beta 1.53
Analysts Strong Sell
Price Target $16.33

Company Profile

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washing...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 210 2217
Address:
22722 29th Dr. SE, Suite 100, Bothell, United States
Fabsdad
Fabsdad Sep. 12 at 12:15 AM
$ACHV lot of bandwagon jumpers showing up lately.
0 · Reply
estatebuyersmia
estatebuyersmia Sep. 11 at 10:03 PM
$ACHV THIS STOCK IS A BUY......
1 · Reply
estatebuyersmia
estatebuyersmia Sep. 11 at 9:58 PM
$ACHV IF YOU CANT DRAW A CONCLUSION FROM THIS.....
0 · Reply
estatebuyersmia
estatebuyersmia Sep. 11 at 9:56 PM
$ACHV READ THIS...
0 · Reply
estatebuyersmia
estatebuyersmia Sep. 11 at 9:56 PM
$ACHV WHY THIS STOCK IS A NO BRAINER
0 · Reply
mhbrown24
mhbrown24 Sep. 11 at 9:19 PM
$ACHV Why would the executives have sold such a high percentage of shares in September? https://www.tradingview.com/news/tradingview:d9a51d6dfbd9a:0-executives-at-achieve-life-sciences-engage-in-stock-transactions/
2 · Reply
mhbrown24
mhbrown24 Sep. 11 at 9:10 PM
$ACHV Thoughts on today's announcement that Cindy Jacobs is being replaced? Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer
1 · Reply
Sieppo
Sieppo Sep. 11 at 6:39 PM
$ACHV just as with the thus far nearly identical last rip, next resistance levels are: 3.3ish, 3.8ish, 4.3ish. After that 5.2ish and 5.5 - we probably have plenty of time for that before next June..
0 · Reply
Gaelic73
Gaelic73 Sep. 11 at 4:46 PM
$ACHV Does this help or hurt us?? https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-fast-track-nicotine-pouch-reviews-amid-white-house-pressure-2025-09-09/
1 · Reply
DSTOCK80
DSTOCK80 Sep. 11 at 3:39 PM
$ACHV over 3.4 🔥
1 · Reply
Latest News on ACHV
Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer

Sep 11, 2025, 5:01 PM EDT - 8 hours ago

Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer

Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation

Sep 3, 2025, 8:30 AM EDT - 8 days ago

Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

Sep 2, 2025, 8:30 AM EDT - 9 days ago

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years

Aug 21, 2025, 2:11 PM EDT - 21 days ago

Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years

Achieve Life Sciences, Inc. (ACHV) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 10:12 AM EDT - 4 weeks ago

Achieve Life Sciences, Inc. (ACHV) Q2 2025 Earnings Call Transcript

Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program

Aug 7, 2025, 7:30 AM EDT - 5 weeks ago

Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program

Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference

Jul 29, 2025, 8:30 AM EDT - 6 weeks ago

Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference

Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 7, 2025

Jul 24, 2025, 8:30 AM EDT - 7 weeks ago

Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 7, 2025

Achieve Life Sciences: Nearing Commercialization Of A Best-In-Class Pharmaceutical Product For Smoking Cessation

Jul 7, 2025, 1:55 PM EDT - 2 months ago

Achieve Life Sciences: Nearing Commercialization Of A Best-In-Class Pharmaceutical Product For Smoking Cessation

Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters' Option to Purchase Additional Securities

Jun 30, 2025, 7:52 PM EDT - 2 months ago

Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters' Option to Purchase Additional Securities

Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering

Jun 26, 2025, 11:43 PM EDT - 2 months ago

Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering

Achieve Life Sciences Announces Proposed Underwritten Public Offering

Jun 26, 2025, 4:03 PM EDT - 2 months ago

Achieve Life Sciences Announces Proposed Underwritten Public Offering

Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades

Jun 26, 2025, 4:02 PM EDT - 2 months ago

Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades

OMC

Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk

Jun 3, 2025, 6:28 PM EDT - 3 months ago

Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk

Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference

May 28, 2025, 8:30 AM EDT - 3 months ago

Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference

Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake

May 20, 2025, 8:30 AM EDT - 4 months ago

Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake

Achieve Life Sciences, Inc. (ACHV) Q1 2025 Earnings Call Transcript

May 13, 2025, 12:16 PM EDT - 4 months ago

Achieve Life Sciences, Inc. (ACHV) Q1 2025 Earnings Call Transcript

Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program

May 13, 2025, 7:30 AM EDT - 4 months ago

Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program

Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025

May 6, 2025, 8:30 AM EDT - 4 months ago

Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025

Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine

Apr 21, 2025, 11:19 AM EDT - 5 months ago

Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine

Achieve Life Sciences, Inc. (ACHV) Q4 2024 Earnings Call Transcript

Mar 11, 2025, 2:52 PM EDT - 6 months ago

Achieve Life Sciences, Inc. (ACHV) Q4 2024 Earnings Call Transcript

Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program

Mar 11, 2025, 7:30 AM EDT - 6 months ago

Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program

Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference

Mar 7, 2025, 8:30 AM EST - 6 months ago

Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025

Mar 6, 2025, 8:30 AM EST - 6 months ago

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025

Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences Conference

Feb 11, 2025, 8:30 AM EST - 7 months ago

Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences Conference

Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial

Feb 10, 2025, 8:30 AM EST - 7 months ago

Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial

Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors

Jan 10, 2025, 8:30 AM EST - 8 months ago

Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors

Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission

Jan 7, 2025, 8:30 AM EST - 8 months ago

Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission

Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week

Jan 6, 2025, 8:30 AM EST - 8 months ago

Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week

Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

Dec 9, 2024, 8:30 AM EST - 9 months ago

Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA

Dec 3, 2024, 8:30 AM EST - 10 months ago

Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA

Smoking Cessation Pipeline Insight 2024, with Focus on Emerging Drugs Cytisinicline (Achieve Life Sciences), EMB-001(Embera Pharmaceuticals) and SBP-9330 (Camino Pharma)

Nov 25, 2024, 7:54 AM EST - 10 months ago

Smoking Cessation Pipeline Insight 2024, with Focus on Emerging Drugs Cytisinicline (Achieve Life Sciences), EMB-001(Embera Pharmaceuticals) and SBP-9330 (Camino Pharma)

Achieve Life Sciences, Inc. (ACHV) Q3 2024 Earnings Call Transcript

Nov 9, 2024, 7:32 AM EST - 10 months ago

Achieve Life Sciences, Inc. (ACHV) Q3 2024 Earnings Call Transcript

Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting

Oct 23, 2024, 8:00 AM EDT - 11 months ago

Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting

Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline

Oct 16, 2024, 8:00 AM EDT - 11 months ago

Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline

Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs

Oct 1, 2024, 8:45 AM EDT - 1 year ago

Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs

Achieve Life Sciences Announces Changes in Executive Leadership and Board of Directors

Aug 26, 2024, 4:30 PM EDT - 1 year ago

Achieve Life Sciences Announces Changes in Executive Leadership and Board of Directors

Achieve Life Sciences, Inc. (ACHV) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:58 AM EDT - 1 year ago

Achieve Life Sciences, Inc. (ACHV) Q2 2024 Earnings Call Transcript

Achieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate Update

Aug 13, 2024, 4:01 PM EDT - 1 year ago

Achieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate Update

Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence

Jul 31, 2024, 8:00 AM EDT - 1 year ago

Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence

Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley Bank

Jul 29, 2024, 8:00 AM EDT - 1 year ago

Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley Bank

Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024

Jul 25, 2024, 8:00 AM EDT - 1 year ago

Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024

Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024

Jul 9, 2024, 8:00 AM EDT - 1 year ago

Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024

Achieve Life Sciences: 1st Half 2025 NDA Filing On Track With FDA Agreement

Jul 1, 2024, 1:46 PM EDT - 1 year ago

Achieve Life Sciences: 1st Half 2025 NDA Filing On Track With FDA Agreement

Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting

May 17, 2024, 8:00 AM EDT - 1 year ago

Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting

Achieve Life Sciences, Inc. (ACHV) Q1 2024 Earnings Call Transcript

May 9, 2024, 7:58 PM EDT - 1 year ago

Achieve Life Sciences, Inc. (ACHV) Q1 2024 Earnings Call Transcript

Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update

May 9, 2024, 4:01 PM EDT - 1 year ago

Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update

Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine

May 6, 2024, 11:16 AM EDT - 1 year ago

Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine

Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024

Apr 25, 2024, 8:00 AM EDT - 1 year ago

Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024

Achieve Life Sciences: An Excellent Drug Addressing A Large Market Could Drive 5x Returns

Apr 4, 2024, 6:30 AM EDT - 1 year ago

Achieve Life Sciences: An Excellent Drug Addressing A Large Market Could Drive 5x Returns

Fabsdad
Fabsdad Sep. 12 at 12:15 AM
$ACHV lot of bandwagon jumpers showing up lately.
0 · Reply
estatebuyersmia
estatebuyersmia Sep. 11 at 10:03 PM
$ACHV THIS STOCK IS A BUY......
1 · Reply
estatebuyersmia
estatebuyersmia Sep. 11 at 9:58 PM
$ACHV IF YOU CANT DRAW A CONCLUSION FROM THIS.....
0 · Reply
estatebuyersmia
estatebuyersmia Sep. 11 at 9:56 PM
$ACHV READ THIS...
0 · Reply
estatebuyersmia
estatebuyersmia Sep. 11 at 9:56 PM
$ACHV WHY THIS STOCK IS A NO BRAINER
0 · Reply
mhbrown24
mhbrown24 Sep. 11 at 9:19 PM
$ACHV Why would the executives have sold such a high percentage of shares in September? https://www.tradingview.com/news/tradingview:d9a51d6dfbd9a:0-executives-at-achieve-life-sciences-engage-in-stock-transactions/
2 · Reply
mhbrown24
mhbrown24 Sep. 11 at 9:10 PM
$ACHV Thoughts on today's announcement that Cindy Jacobs is being replaced? Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer
1 · Reply
Sieppo
Sieppo Sep. 11 at 6:39 PM
$ACHV just as with the thus far nearly identical last rip, next resistance levels are: 3.3ish, 3.8ish, 4.3ish. After that 5.2ish and 5.5 - we probably have plenty of time for that before next June..
0 · Reply
Gaelic73
Gaelic73 Sep. 11 at 4:46 PM
$ACHV Does this help or hurt us?? https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-fast-track-nicotine-pouch-reviews-amid-white-house-pressure-2025-09-09/
1 · Reply
DSTOCK80
DSTOCK80 Sep. 11 at 3:39 PM
$ACHV over 3.4 🔥
1 · Reply
Gaelic73
Gaelic73 Sep. 11 at 2:42 PM
$ACHV Everything I have is green except this. I thought we would continue the upward trend we've had this week.
0 · Reply
Jonita
Jonita Sep. 11 at 1:46 PM
$ACHV FDA accepted the NDA. PDUFA set to Jun 20, 2026
0 · Reply
estatebuyersmia
estatebuyersmia Sep. 11 at 11:50 AM
$ACHV Its funny how people pan a stock when it rises...
0 · Reply
estatebuyersmia
estatebuyersmia Sep. 11 at 11:29 AM
$ACHV THE NUMBERS DONT LIE ED NG
0 · Reply
estatebuyersmia
estatebuyersmia Sep. 11 at 11:28 AM
$ACHV FYI
0 · Reply
estatebuyersmia
estatebuyersmia Sep. 11 at 11:21 AM
$ACHV CEO HAS HAD A STELLAR TRACK RECORD
0 · Reply
estatebuyersmia
estatebuyersmia Sep. 11 at 11:20 AM
$ACHV COMPUTER CACULATED
0 · Reply
stockflippper
stockflippper Sep. 11 at 2:13 AM
$ACHV https://x.com/mjtruthultra/status/1965828442819064045?s=46&t=mTz05Krtvc7Jxu1ivD1Jtg
0 · Reply
Ed_Ng
Ed_Ng Sep. 11 at 12:50 AM
$ACHV stupid stock. From 7000$ to 3$ is completely unacceptable and smell like scam! Don't touch!
6 · Reply
estatebuyersmia
estatebuyersmia Sep. 11 at 12:42 AM
$ACHV THIS STOCK IS MOVING HIGHER, IT TRADES BEAUTIFULLY CREEPING UP AT A SLOW DILBERATE CRAWL... ALL THE PIECES ARE STARTING TO FIT TOGETHER...
0 · Reply
Stockwitzzz
Stockwitzzz Sep. 10 at 10:30 PM
$ACHV
3 · Reply
estatebuyersmia
estatebuyersmia Sep. 10 at 5:42 PM
$ABCL FROM $ACHV
0 · Reply